Fulgent Genetics ROE 2015-2023 | FLGT

Current and historical return on equity (ROE) values for Fulgent Genetics (FLGT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Fulgent Genetics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $-0.17B $1.13B -13.56%
2023-09-30 $-0.06B $1.26B -4.98%
2023-06-30 $-0.05B $1.26B -3.78%
2023-03-31 $-0.03B $1.27B -1.95%
2022-12-31 $0.14B $1.27B 11.13%
2022-09-30 $0.27B $1.28B 21.46%
2022-06-30 $0.39B $1.31B 32.52%
2022-03-31 $0.46B $1.31B 41.49%
2021-12-31 $0.51B $1.17B 51.67%
2021-09-30 $0.57B $1.04B 68.35%
2021-06-30 $0.49B $0.92B 79.71%
2021-03-31 $0.42B $0.80B 101.40%
2020-12-31 $0.21B $0.57B 92.64%
2020-09-30 $0.05B $0.19B 43.84%
2020-06-30 $0.00B $0.09B 2.61%
2020-03-31 $-0.00B $0.08B -1.48%
2019-12-31 $-0.00B $0.08B -1.67%
2019-09-30 $-0.00B $0.06B -5.80%
2019-06-30 $-0.01B $0.05B -9.76%
2019-03-31 $-0.01B $0.05B -11.59%
2018-12-31 $-0.01B $0.05B -11.43%
2018-09-30 $-0.01B $0.05B -11.27%
2018-06-30 $-0.01B $0.05B -11.16%
2018-03-31 $-0.01B $0.05B -9.17%
2017-12-31 $-0.00B $0.05B -5.45%
2017-09-30 $0.00B $0.06B 0.00%
2017-06-30 $0.00B $0.06B 0.00%
2017-03-31 $-0.01B $0.06B -13.51%
2016-12-31 $-0.01B $0.05B -25.81%
2016-06-30 $-0.01B $0.02B -109.09%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.620B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.573B 22.01
Inspire Medical Systems (INSP) United States $7.095B 0.00
IRhythm Technologies (IRTC) United States $3.623B 0.00
Axonics (AXNX) United States $3.399B 0.00
10x Genomics (TXG) United States $3.279B 0.00
Enovis (ENOV) United States $3.080B 23.40
Azenta (AZTA) United States $2.905B 236.77
Olink Holding AB (publ) (OLK) Sweden $2.789B 0.00
Hims & Hers Health (HIMS) United States $2.644B 0.00
Privia Health (PRVA) United States $2.156B 95.63
Schrodinger (SDGR) United States $1.738B 0.00
Omnicell (OMCL) United States $1.260B 30.82
Phreesia (PHR) United States $1.237B 0.00
Definitive Healthcare (DH) United States $0.854B 0.00
Standard BioTools (LAB) United States $0.702B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Clover Health Investments (CLOV) United States $0.322B 0.00
Pulmonx (LUNG) United States $0.290B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
P3 Health Partners (PIII) United States $0.158B 0.00
American Well (AMWL) United States $0.154B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.132B 0.00
TruBridge (TBRG) United States $0.116B 4.95
111 (YI) China $0.088B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00